DYN logo

Dyne Therapeutics (DYN) Working capital

annual working capital:

$617.02M+$538.74M(+688.22%)
December 31, 2024

Summary

  • As of today (May 29, 2025), DYN annual working capital is $617.02 million, with the most recent change of +$538.74 million (+688.22%) on December 31, 2024.
  • During the last 3 years, DYN annual working capital has risen by +$263.35 million (+74.46%).
  • DYN annual working capital is now at all-time high.

Performance

DYN Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNbalance sheet metrics

quarterly working capital:

$655.62M+$38.60M(+6.26%)
March 31, 2025

Summary

  • As of today (May 29, 2025), DYN quarterly working capital is $655.62 million, with the most recent change of +$38.60 million (+6.26%) on March 31, 2025.
  • Over the past year, DYN quarterly working capital has increased by +$189.84 million (+40.76%).
  • DYN quarterly working capital is now -14.02% below its all-time high of $762.57 million, reached on June 30, 2024.

Performance

DYN quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

DYN Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+688.2%+40.8%
3 y3 years+74.5%+104.1%
5 y5 years+4875.6%-

DYN Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+688.2%-14.0%+737.5%
5 y5-yearat high+4875.6%-14.0%+737.5%
alltimeall timeat high+8185.5%-14.0%+5186.8%

DYN Working capital History

DateAnnualQuarterly
Mar 2025
-
$655.62M(+6.3%)
Dec 2024
$617.02M(+688.2%)
$617.02M(-11.0%)
Sep 2024
-
$693.13M(-9.1%)
Jun 2024
-
$762.57M(+63.7%)
Mar 2024
-
$465.78M(+495.0%)
Dec 2023
$78.28M(-67.0%)
$78.28M(-43.5%)
Sep 2023
-
$138.52M(-28.2%)
Jun 2023
-
$192.95M(-15.2%)
Mar 2023
-
$227.63M(-4.2%)
Dec 2022
$237.51M
$237.51M(+1.1%)
Sep 2022
-
$234.91M(-13.7%)
DateAnnualQuarterly
Jun 2022
-
$272.31M(-15.2%)
Mar 2022
-
$321.21M(-9.2%)
Dec 2021
$353.67M(+4.6%)
$353.67M(-11.9%)
Sep 2021
-
$401.30M(-10.2%)
Jun 2021
-
$446.75M(-5.7%)
Mar 2021
-
$473.62M(+40.1%)
Dec 2020
$338.12M(+2626.6%)
$338.12M(-9.9%)
Sep 2020
-
$375.16M(+166.2%)
Jun 2020
-
$140.95M(+1036.6%)
Dec 2019
$12.40M(+66.5%)
$12.40M
Dec 2018
$7.45M
-

FAQ

  • What is Dyne Therapeutics annual working capital?
  • What is the all time high annual working capital for Dyne Therapeutics?
  • What is Dyne Therapeutics annual working capital year-on-year change?
  • What is Dyne Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Dyne Therapeutics?
  • What is Dyne Therapeutics quarterly working capital year-on-year change?

What is Dyne Therapeutics annual working capital?

The current annual working capital of DYN is $617.02M

What is the all time high annual working capital for Dyne Therapeutics?

Dyne Therapeutics all-time high annual working capital is $617.02M

What is Dyne Therapeutics annual working capital year-on-year change?

Over the past year, DYN annual working capital has changed by +$538.74M (+688.22%)

What is Dyne Therapeutics quarterly working capital?

The current quarterly working capital of DYN is $655.62M

What is the all time high quarterly working capital for Dyne Therapeutics?

Dyne Therapeutics all-time high quarterly working capital is $762.57M

What is Dyne Therapeutics quarterly working capital year-on-year change?

Over the past year, DYN quarterly working capital has changed by +$189.84M (+40.76%)
On this page